Harold C. Standiford
-
- Antibiotic Use and Resistance 9
- Molecular Medicine top 0.2%
- Antibiotic Resistance in Bacteria 35
- Clinical Biochemistry top 0.2%
- Bacterial Identification and Susceptibility Testing 27
- Pharmacology top 0.2%
- Antibiotics Pharmacokinetics and Efficacy 46
- Infectious Diseases top 0.5%
- Antimicrobial Resistance in Staphylococcus 27
- HIV/AIDS drug development and treatment 8
-
- Neutropenia and Cancer Infections 12
-
- Pneumonia and Respiratory Infections 9
Harold C. Standiford
90 papers receiving 4.2k citations
Hit Papers
Peers
Comparison fields: 5 of 138
- Applied Microbiology and Biotechnology 668
- Molecular Medicine 1.4k
- Clinical Biochemistry 1.2k
- Pharmacology 1.6k
- Infectious Diseases 1.6k
Countries citing papers authored by Harold C. Standiford
This map shows the geographic impact of Harold C. Standiford's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harold C. Standiford with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harold C. Standiford more than expected).
Fields of papers citing papers by Harold C. Standiford
This network shows the impact of papers produced by Harold C. Standiford. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harold C. Standiford. The network helps show where Harold C. Standiford may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Harold C. Standiford, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 3 | |
| 2 | 2012 | 170 | |
| 3 | 2007 | 20 | |
| 4 | 2007 | 13 | |
| 5 | 2001 | 58 | |
| 6 | 2001 | 90 | |
| 7 | 1999 | 15 | |
| 8 | 1999 | 12 | |
| 9 | 1998 | 31 | |
| 10 | 1993 | 5 | |
| 11 | Methicillin-resistant Staphylococcus aureus: A consensus review of the microbiology, pathogenesis, and epidemiology with implications for prevention and managementbreakdown → | 1993 | 542 |
| 12 | 1992 | 227 | |
| 13 | Characterization of enterococcal strains exhibiting a novel glycopeptide susceptibility pattern | 1991 | 1 |
| 14 | 1990 | 42 | |
| 15 | 1990 | 9 | |
| 16 | 1989 | 26 | |
| 17 | 1988 | 13 | |
| 18 | 1984 | 10 | |
| 19 | 1984 | 32 | |
| 20 | 1976 | 33 |
About Harold C. Standiford
Harold C. Standiford is a scholar working on Molecular Medicine, Applied Microbiology and Biotechnology and Clinical Biochemistry, having authored 92 papers that have together received 4.5k indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (46 papers), Antibiotic Resistance in Bacteria (35 papers), Antimicrobial Resistance in Staphylococcus (27 papers), Bacterial Identification and Susceptibility Testing (27 papers), Neutropenia and Cancer Infections (12 papers), Pneumonia and Respiratory Infections (9 papers), Antibiotic Use and Resistance (9 papers) and HIV/AIDS drug development and treatment (8 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (668 citations), Molecular Medicine (1.4k citations) and Clinical Biochemistry (1.2k citations). Harold C. Standiford has collaborated with scholars based in United States, Israel and Venezuela. Frequent co-authors include George L. Drusano, Beverly A. Tatem, Karen I. Plaisance, Dachelle Johnson, Alan Forrest, Marc Rosen, Joan Hebden, Bruce S. Ribner, Maury E. Mulligan and Joseph F. John. Their work appears in journals such as JAMA, Clinical Infectious Diseases and The American Journal of Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.